This Friday's meeting is certainly going to be intriguing as the dissident group of shareholders in Progen Pharmaceuticals said on Monday it had substantial support to unseat the current board of the cancer drug developer on Friday.
http://news.smh.com.au/business/stocks-to-watch-20090106-7anv.html